A detailed history of Chris Bulman Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Chris Bulman Inc holds 500 shares of NVO stock, worth $66,030. This represents 0.05% of its overall portfolio holdings.

Number of Shares
500
Holding current value
$66,030
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $61,355 - $73,455
500 New
500 $71.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $298B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Chris Bulman Inc Portfolio

Follow Chris Bulman Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chris Bulman Inc, based on Form 13F filings with the SEC.

News

Stay updated on Chris Bulman Inc with notifications on news.